Seuraa
Matthew E. Monroe
Matthew E. Monroe
Vahvistettu sähköpostiosoite verkkotunnuksessa pnnl.gov
Nimike
Viittaukset
Viittaukset
Vuosi
Integrated proteogenomic characterization of human high-grade serous ovarian cancer
H Zhang, T Liu, Z Zhang, SH Payne, B Zhang, JE McDermott, JY Zhou, ...
Cell 166 (3), 755-765, 2016
8832016
Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome
SM Varnum, DN Streblow, ME Monroe, P Smith, KJ Auberry, ...
Journal of virology 78 (20), 10960-10966, 2004
8162004
Reversed‐phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cells
Y Wang, F Yang, MA Gritsenko, Y Wang, T Clauss, T Liu, Y Shen, ...
Proteomics 11 (10), 2019-2026, 2011
5842011
Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities
S Vasaikar, C Huang, X Wang, VA Petyuk, SR Savage, B Wen, Y Dou, ...
Cell 177 (4), 1035-1049. e19, 2019
5562019
Human Plasma N-Glycoproteome Analysis by Immunoaffinity Subtraction, Hydrazide Chemistry, and Mass Spectrometry
T Liu, WJ Qian, MA Gritsenko, DG Camp, ME Monroe, RJ Moore, ...
Journal of proteome research 4 (6), 2070-2080, 2005
4892005
Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma
MA Gillette, S Satpathy, S Cao, SM Dhanasekaran, SV Vasaikar, K Krug, ...
Cell 182 (1), 200-225. e35, 2020
4422020
Integrated proteogenomic characterization of clear cell renal cell carcinoma
DJ Clark, SM Dhanasekaran, F Petralia, J Pan, X Song, Y Hu, ...
Cell 179 (4), 964-983. e31, 2019
4362019
Probability-based evaluation of peptide and protein identifications from tandem mass spectrometry and SEQUEST analysis: the human proteome
WJ Qian, T Liu, ME Monroe, EF Strittmatter, JM Jacobs, LJ Kangas, ...
Journal of proteome research 4 (1), 53-62, 2005
3842005
Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography–mass spectrometry
P Mertins, LC Tang, K Krug, DJ Clark, MA Gritsenko, L Chen, KR Clauser, ...
Nature protocols 13 (7), 1632-1661, 2018
3772018
Proteogenomic and metabolomic characterization of human glioblastoma
LB Wang, A Karpova, MA Gritsenko, JE Kyle, S Cao, Y Li, D Rykunov, ...
Cancer cell 39 (4), 509-528. e20, 2021
3762021
Advances in proteomics data analysis and display using an accurate mass and time tag approach
JSD Zimmer, ME Monroe, WJ Qian, RD Smith
Mass spectrometry reviews 25 (3), 450-482, 2006
3692006
Proteogenomic characterization of endometrial carcinoma
Y Dou, EA Kawaler, DC Zhou, MA Gritsenko, C Huang, L Blumenberg, ...
Cell 180 (4), 729-748. e26, 2020
3182020
Tandem mass spectrometry identifies many mouse brain O-GlcNAcylated proteins including EGF domain-specific O-GlcNAc transferase targets
JF Alfaro, CX Gong, ME Monroe, JT Aldrich, TRW Clauss, SO Purvine, ...
Proceedings of the National Academy of Sciences 109 (19), 7280-7285, 2012
3162012
Integrative analysis of the mitochondrial proteome in yeast
H Prokisch, C Scharfe, DG Camp, W Xiao, L David, C Andreoli, ...
PLoS Biology 2 (6), e160, 2004
2492004
Uncovering biologically significant lipid isomers with liquid chromatography, ion mobility spectrometry and mass spectrometry
JE Kyle, X Zhang, KK Weitz, ME Monroe, YM Ibrahim, RJ Moore, J Cha, ...
Analyst 141 (5), 1649-1659, 2016
2392016
VIPER: an advanced software package to support high-throughput LC-MS peptide identification
ME Monroe, N Tolić, N Jaitly, JL Shaw, JN Adkins, RD Smith
Bioinformatics 23 (15), 2021-2023, 2007
2272007
Improved peptide elution time prediction for reversed-phase liquid chromatography-MS by incorporating peptide sequence information
K Petritis, LJ Kangas, B Yan, ME Monroe, EF Strittmatter, WJ Qian, ...
Analytical chemistry 78 (14), 5026-5039, 2006
2142006
MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape
VD Menachery, A Schäfer, KE Burnum-Johnson, HD Mitchell, AJ Eisfeld, ...
Proceedings of the National Academy of Sciences 115 (5), E1012-E1021, 2018
1982018
Quantitative Proteome Analysis of Human Plasma following in Vivo Lipopolysaccharide Administration Using 16O/18O Labeling and the Accurate Mass and Time Tag Approach* S
WJ Qian, ME Monroe, T Liu, JM Jacobs, GA Anderson, Y Shen, RJ Moore, ...
Molecular & Cellular Proteomics 4 (5), 700-709, 2005
1972005
Integrated proteogenomic characterization across major histological types of pediatric brain cancer
F Petralia, N Tignor, B Reva, M Koptyra, S Chowdhury, D Rykunov, A Krek, ...
Cell 183 (7), 1962-1985. e31, 2020
1962020
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20